Literature DB >> 3356066

Development of techniques to monitor for exposure to vinyl chloride: monoclonal antibodies to ethenoadenosine and ethenocytidine.

T L Young1, R M Santella.   

Abstract

Monoclonal antibodies which specifically recognize ethenoadenosine and ethenocytidine, two of the adducts resulting from exposure to vinyl chloride, have been developed. The sensitivity and specificity of these antibodies have been determined by enzyme-linked immunosorbent assay (ELISA). The antibody to ethenoadenosine (1G4) reacts with both the ribose (50% inhibition at 600 fmol) and deoxyribose (50% inhibition at 980 fmol) form of the adduct. The antibody to ethenocytidine (6F5) also reacts with both the ribose (50% inhibition at 800 fmol) and deoxyribose (50% inhibition at 1000 fmol) form of the adduct. Neither antibody cross-reacts with non-modified DNA or the normal nucleotides. A more sensitive fluorescence ELISA was developed for antibody 1G4 with 50% inhibition at 212 fmol of ethenoadenosine and for antibody 6F5 with 50% inhibition at 192 fmol ethenocytidine. These antibodies have been used to determine the level of etheno derivatives in DNA modified in vitro with chloroacetaldehyde and in the DNA and RNA of cells treated in culture.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356066     DOI: 10.1093/carcin/9.4.589

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Mono-ADP-ribosyltransferases in human monocytes: regulation by lipopolysaccharide.

Authors:  Andreas Grahnert; Maik Friedrich; Martin Pfister; Friedrich Haag; Friedrich Koch-Nolte; Sunna Hauschildt
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

2.  Proteomics approaches to identify mono-(ADP-ribosyl)ated and poly(ADP-ribosyl)ated proteins.

Authors:  Christina A Vivelo; Anthony K L Leung
Journal:  Proteomics       Date:  2014-12-15       Impact factor: 3.984

3.  In vivo detection and imaging of phosphatidylserine expression during programmed cell death.

Authors:  F G Blankenberg; P D Katsikis; J F Tait; R E Davis; L Naumovski; K Ohtsuki; S Kopiwoda; M J Abrams; M Darkes; R C Robbins; H T Maecker; H W Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice.

Authors:  Wiebke Ohlrogge; Friedrich Haag; Jürgen Löhler; Michel Seman; Dan R Littman; Nigel Killeen; Friedrich Koch-Nolte
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

5.  Monitoring human exposure to carcinogens by DNA adduct measurement.

Authors:  R M Santella
Journal:  Cell Biol Toxicol       Date:  1988-12       Impact factor: 6.691

6.  A macrodomain-linked immunosorbent assay (MLISA) for mono-ADP-ribosyltransferases.

Authors:  Jingwen Chen; Albert T Lam; Yong Zhang
Journal:  Anal Biochem       Date:  2017-12-13       Impact factor: 3.365

7.  Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microglia.

Authors:  Björn Rissiek; Stephan Menzel; Mario Leutert; Maike Cordes; Sarah Behr; Larissa Jank; Peter Ludewig; Mathias Gelderblom; Anne Rissiek; Sahil Adriouch; Friedrich Haag; Michael O Hottiger; Friedrich Koch-Nolte; Tim Magnus
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

8.  Effect of the XRCC1 codon 399 polymorphism on the repair of vinyl chloride metabolite-induced DNA damage.

Authors:  Yongliang Li; Changmin Long; George Lin; Marie-Jeanne Marion; Greg Freyer; Regina M Santella; Paul W Brandt-Rauf
Journal:  J Carcinog       Date:  2009

9.  The orthologue of the "acatalytic" mammalian ART4 in chicken is an arginine-specific mono-ADP-ribosyltransferase.

Authors:  Andreas Grahnert; Steffi Richter; Fritzi Siegert; Angela Berndt; Sunna Hauschildt
Journal:  BMC Mol Biol       Date:  2008-10-14       Impact factor: 2.946

10.  Identification of two regulatory binding sites which confer myotube specific expression of the mono-ADP-ribosyltransferase ART1 gene.

Authors:  Maik Friedrich; Levin Böhlig; Ralf D Kirschner; Kurt Engeland; Sunna Hauschildt
Journal:  BMC Mol Biol       Date:  2008-10-21       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.